ROBIN LEVY — Lobbyist Profile | Poliscope

ROBIN LEVY

Filings

Clients

Firms

Years active

2016–2022

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
INTERNATIONAL MYELOMA FOUNDATION	40	2016–2022

Lobbying firms

Firm	Filings	Years
INTERNATIONAL MYELOMA FOUNDATION	40	2016–2022

Bills explicitly cited in this lobbyist’s assigned issues (18)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 1730

Cancer Drug Parity Act of 2019

Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: INTERNATIONAL MYELOMA FOUNDATION

Open original LDA filing ↗

Cited source text

HR 1730/S.741 Cancer Issues - Multiple Myeloma

H.R. 1730

Cancer Drug Parity Act of 2019

Client: INTERNATIONAL MYELOMA FOUNDATION · Firm: INTERNATIONAL MYELOMA FOUNDATION

Open original LDA filing ↗

Cited source text

HR 1730/S.741 Cancer Issues - Multiple Myeloma

Original LDA source filings (40)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2022 · third_quarter · 3A

Firm income: —Client expense: $43,879Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

DEF

Defense

CDMRP

BUD

Budget/Appropriations

CDMRP

HCR

Health Issues

Oral Parity; CDMRP; Cancer Research Funding

Source: Senate LDA

Show 36 more original filings

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2022 · second_quarter · Q2

Firm income: —Client expense: $69,514Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

DEF

Defense

CDMRP

BUD

Budget/Appropriations

CDMRP

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2022 · first_quarter · Q1

Firm income: —Client expense: $69,514Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

DEF

Defense

CDMRP

BUD

Budget/Appropriations

CDMRP

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2021 · fourth_quarter · Q4

Firm income: —Client expense: $69,514Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

CDMRP

DEF

Defense

CDMRP

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2021 · third_quarter · Q3

Firm income: —Client expense: $69,514Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

CDMRP

DEF

Defense

CDMRP

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2021 · second_quarter · Q2

Firm income: —Client expense: $69,515Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

DEF

Defense

CDMRP

BUD

Budget/Appropriations

CDMRP

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2021 · first_quarter · 1A

Firm income: —Client expense: $28,872Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

BUD

Budget/Appropriations

CDMRP

DEF

Defense

CDMRP

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2021 · first_quarter · Q1

Firm income: —Client expense: $69,488Open original LDA filing ↗

Assigned issues and filing targets (2 issues)

DEF

Defense

CDMRP

BUD

Budget/Appropriations

CDMRP

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2020 · fourth_quarter · 4A

Firm income: —Client expense: $69,489Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

DEF

Defense

CDMRP

BUD

Budget/Appropriations

Department of Defense Cancer Research Program

HCR

Health Issues

HR 1730/S.741 Cancer Issues - Multiple Myeloma

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2020 · fourth_quarter · Q4

Firm income: —Client expense: $66,733Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

BUD

Budget/Appropriations

Department of Defense Cancer Research Program

HCR

Health Issues

HR 1730/S.741 Cancer Issues - Multiple Myeloma

DEF

Defense

CDMRP

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2020 · third_quarter · 3A

Firm income: —Client expense: $66,733Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

BUD

Budget/Appropriations

Department of Defense Cancer Research Program

HCR

Health Issues

HR 1730/S.741 Cancer Issues - Multiple Myeloma

DEF

Defense

CDMRP

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2020 · third_quarter · Q3

Firm income: —Client expense: $61,515Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

DEF

Defense

CDMRP

BUD

Budget/Appropriations

Department of Defense Cancer Research Program

HCR

Health Issues

HR 1730/S.741 Cancer Issues - Multiple Myeloma

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2020 · second_quarter · Q2

Firm income: —Client expense: $61,515Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

HCR

Health Issues

HR 1730/S.741 Cancer Issues - Multiple Myeloma

DEF

Defense

CDMRP

BUD

Budget/Appropriations

Department of Defense Cancer Research Program

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2020 · first_quarter · 1A

Firm income: —Client expense: $65,462Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

DEF

Defense

CDMRP

HCR

Health Issues

HR 1730/S.741 Cancer Issues - Multiple Myeloma

BUD

Budget/Appropriations

Department of Defense Cancer Research Program

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2020 · first_quarter · Q1

Firm income: —Client expense: $56,508Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

DEF

Defense

CDMRP

HCR

Health Issues

HR 1730/S.741 Cancer Issues - Multiple Myeloma

BUD

Budget/Appropriations

Department of Defense Cancer Research Program

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2019 · fourth_quarter · Q4

Firm income: —Client expense: $58,238Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

HCR

Health Issues

Department of Defense Oral Parity

BUD

Budget/Appropriations

CDMRP

VET

Veterans

CDMRP

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2019 · second_quarter · 2A

Firm income: —Client expense: $53,664Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

HCR

Health Issues

Department of Defense Oral Parity

BUD

Budget/Appropriations

CDMRP

VET

Veterans

CDMRP

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2019 · third_quarter · 3A

Firm income: —Client expense: $70,450Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

VET

Veterans

CDMRP

BUD

Budget/Appropriations

CDMRP

HCR

Health Issues

Department of Defense Oral Parity

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2019 · third_quarter · Q3

Firm income: —Client expense: $65,016Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

BUD

Budget/Appropriations

CDMRP

HCR

Health Issues

Department of Defense Oral Parity

VET

Veterans

CDMRP

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2019 · second_quarter · Q2

Firm income: —Client expense: $65,016Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

BUD

Budget/Appropriations

CDMRP

HCR

Health Issues

Department of Defense Oral Parity

VET

Veterans

CDMRP

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2019 · first_quarter · 1A

Firm income: —Client expense: $65,016Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

VET

Veterans

CDMRP

BUD

Budget/Appropriations

CDMRP

HCR

Health Issues

Department of Defense Oral Parity

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2019 · first_quarter · Q1

Firm income: —Client expense: $6,475Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

VET

Veterans

CDMRP

HCR

Health Issues

Department of Defense Oral Parity

BUD

Budget/Appropriations

CDMRP

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2018 · fourth_quarter · 4A

Firm income: —Client expense: $56,508Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

VET

Veterans

DoD - CDMRP

HCR

Health Issues

Cancer Drug Coverage Act DoD Appropriations - CDMRP NIH Funding Affordable Care Act

BUD

Budget/Appropriations

DoD Approrprations - CDMRP NIH Funding

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2018 · fourth_quarter · Q4

Firm income: —Client expense: $6,475Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

VET

Veterans

DoD - CDMRP

HCR

Health Issues

Cancer Drug Coverage Act DoD Appropriations - CDMRP NIH Funding Affordable Care Act

BUD

Budget/Appropriations

DoD Approrprations - CDMRP NIH Funding

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2018 · third_quarter · Q3

Firm income: —Client expense: $6,475Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

VET

Veterans

DoD - CDMRP

BUD

Budget/Appropriations

DoD Approrprations - CDMRP NIH Funding

HCR

Health Issues

Cancer Drug Coverage Act DoD Appropriations - CDMRP NIH Funding Affordable Care Act

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2018 · second_quarter · 2A

Firm income: —Client expense: $6,476Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

VET

Veterans

DoD - CDMRP

HCR

Health Issues

Cancer Drug Coverage Act DoD Appropriations - CDMRP NIH Funding Affordable Care Act

BUD

Budget/Appropriations

DoD Approrprations - CDMRP NIH Funding

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2018 · second_quarter · Q2

Firm income: —Client expense: $52,130Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

BUD

Budget/Appropriations

DoD Approrprations - CDMRP NIH Funding

VET

Veterans

DoD - CDMRP

HCR

Health Issues

Cancer Drug Coverage Act DoD Appropriations - CDMRP NIH Funding Affordable Care Act

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2018 · first_quarter · 1A

Firm income: —Client expense: $52,131Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

VET

Veterans

DoD - CDMRP

BUD

Budget/Appropriations

DoD Approrprations - CDMRP NIH Funding

HCR

Health Issues

Cancer Drug Coverage Act DoD Appropriations - CDMRP NIH Funding Affordable Care Act

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2018 · first_quarter · Q1

Firm income: —Client expense: $56,269Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

HCR

Health Issues

Cancer Drug Coverage Act DoD Appropriations - CDMRP NIH Funding Affordable Care Act

BUD

Budget/Appropriations

DoD Approrprations - CDMRP NIH Funding

VET

Veterans

DoD - CDMRP

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2017 · fourth_quarter · Q4

Firm income: —Client expense: $56,269Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

BUD

Budget/Appropriations

DoD Approrprations - CDMRP NIH Funding

HCR

Health Issues

Cancer Drug Coverage Act DoD Appropriations - CDMRP NIH Funding Affordable Care Act

VET

Veterans

DoD - CDMRP

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2017 · third_quarter · Q3

Firm income: —Client expense: $56,269Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

HCR

Health Issues

Cancer Drug Coverage Act DoD Appropriations - CDMRP NIH Funding

BUD

Budget/Appropriations

DoD Approrprations - CDMRP NIH Funding

VET

Veterans

DoD - CDMRP

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2017 · second_quarter · Q2

Firm income: —Client expense: $56,269Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

BUD

Budget/Appropriations

DoD Approrprations - CDMRP NIH Funding

VET

Veterans

DoD - CDMRP

HCR

Health Issues

Cancer Drug Coverage Act DoD Appropriations - CDMRP NIH Funding

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2017 · first_quarter · 1A

Firm income: —Client expense: $39,626Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

BUD

Budget/Appropriations

DoD Approrprations - CDMRP NIH Funding

HCR

Health Issues

Cancer Drug Coverage Act DoD Appropriations - CDMRP NIH Funding

VET

Veterans

DoD - CDMRP

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2017 · first_quarter · Q1

Firm income: —Client expense: $42,005Open original LDA filing ↗

Assigned issues and filing targets (3 issues)

BUD

Budget/Appropriations

DoD Approrprations - CDMRP NIH Funding

VET

Veterans

DoD - CDMRP

HCR

Health Issues

Cancer Drug Coverage Act DoD Appropriations - CDMRP NIH Funding

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2017 · second_quarter · RA

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

MED

Medical/Disease Research/Clinical Labs

Cancer Drug Coverage DoD Appropriations - CDMRP NIH Funding

VET

Veterans

Cancer Drug Coverage DoD Appropriations - CDMRP NIH Funding

BUD

Budget/Appropriations

Cancer Drug Coverage DoD Appropriations - CDMRP NIH Funding

HCR

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2016 · fourth_quarter · 4A

Firm income: —Client expense: $42,005Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

HR 2739 / S 1566, the Cancer Drug Coverage Parity Act of 2015 - insurance coverage equality for oral anticancer medications

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

INTERNATIONAL MYELOMA FOUNDATION via INTERNATIONAL MYELOMA FOUNDATION

2016 · fourth_quarter · Q4

Firm income: —Client expense: $45,703Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

HR 2739 / S 1566, the Cancer Drug Coverage Parity Act of 2015 - insurance coverage equality for oral anticancer medications

Filing targets: HOUSE OF REPRESENTATIVES, SENATE